荃信生物-B(02509)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02509 荃信生物-B

未开盘 07-30 16:08:08

20.150

+1.230

+6.50%

最高20.300	最低18.980	成交量101.60万
今开19.020	昨收18.920	日振幅6.98%
总市值44.73亿	流通市值44.73亿	总股本2.22亿
成交额2,012万	换手率0.46%	流通股本2.22亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02509","market":"HK","secType":"STK","nameCN":"荃信生物-B","latestPrice":20.15,"timestamp":1753862888435,"preClose":18.92,"halted":0,"volume":1016000,"delay":0,"floatShares":222000000,"shares":222000000,"eps":-1.6652368881920294,"marketStatus":"未开盘","change":1.23,"latestTime":"07-30 16:08:08","open":19.02,"high":20.3,"low":18.98,"amount":20120710,"amplitude":0.069767,"askPrice":20.15,"askSize":27400,"bidPrice":20.1,"bidSize":600,"shortable":0,"etf":0,"ttmEps":-1.6652368881920294,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1753925400000},"marketStatusCode":0,"adr":0,"listingDate":1710864000000,"exchange":"SEHK","adjPreClose":18.92,"openAndCloseTimeList":[[1753839000000,1753848000000],[1753851600000,1753862400000]],"volumeRatio":2.1308724829980212,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02509","defaultTab":"news","newsList":[{"id":"2555013051","title":"荃信生物-B07月29日遭主力抛售58.1万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555013051","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555013051?lang=zh_cn&edition=full","pubTime":"2025-07-29 16:16","pubTimestamp":1753776960,"startTime":"0","endTime":"0","summary":"07月29日, 荃信生物-B股价跌0.42%，报收18.92元，成交金额857.1万元，换手率0.20%，振幅5.37%，量比0.82。荃信生物-B今日主力资金净流出58.1万元，上一交易日主力净流出98.0万元。该股近5个交易日上涨3.96%，主力资金累计净流入49.2万元；近20日主力资金累计净流出15.7万元，其中净流出天数为4日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729170311a4695643&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729170311a4695643&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02509"],"gpt_icon":0},{"id":"2554758168","title":"港股异动 | 荃信生物-B(02509)涨超6% 国际化BD为公司今年核心战略 赛乐信今年销售额预计达3亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2554758168","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554758168?lang=zh_cn&edition=full","pubTime":"2025-07-25 11:35","pubTimestamp":1753414514,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，荃信生物-B涨超6%，高见19.88港元创去年10月以来新高，年内股价已累涨逾1.6倍。消息面上，今年6月，荃信生物于泰州举办第二期投资人调研活动。国际化BD是公司今年的核心战略，正围绕刚才提到的两大重点领域积极布局和推进双抗合作。值得一提的是，今年4月，荃信生物公布，与Caldera Therapeutics达成授权合作。荃信生物2024年实现收入人民币1.59亿元；净亏损同比收窄32.92%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1321868.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4579","BK4531","LU0049112450.USD","BK4166","02509","BK1161","LX","LU1235295612.USD","LU1046422090.SGD"],"gpt_icon":0},{"id":"2553079172","title":"荃信生物-B07月24日主力净流入156.2万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2553079172","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553079172?lang=zh_cn&edition=full","pubTime":"2025-07-24 16:15","pubTimestamp":1753344926,"startTime":"0","endTime":"0","summary":"07月24日, 荃信生物-B股价涨2.32%，报收18.50元，成交金额1254.5万元，换手率0.31%，振幅5.53%，量比1.00。荃信生物-B今日主力资金净流入156.2万元，上一交易日主力净流出0万元。该股近5个交易日上涨19.51%，主力资金累计净流入449.1万元；近20日主力资金累计净流入91.3万元，其中净流入天数为5日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724165245a460e993&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724165245a460e993&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02509","BK1161"],"gpt_icon":0},{"id":"2552456049","title":"港股异动 | 荃信生物-B(02509)早盘涨超9% QX029N近日获批临床 QX030N此前达成国际授权合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2552456049","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552456049?lang=zh_cn&edition=full","pubTime":"2025-07-18 11:48","pubTimestamp":1752810513,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，荃信生物-B早盘涨超9%，截至发稿，涨7.49%，报16.64港元，成交额945.85万港元。消息面上，近日，荃信生物生物制品1类新药QX029N注射液获批临床，拟开发治疗成人中度至重度特应性皮炎。此外，荃信生物今年4月公布，与Caldera Therapeutics达成授权合作。此外，荃信生物2024年实现收入人民币1.59亿元；净亏损同比收窄32.92%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1319328.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"港股异动 | 荃信生物-B(02509)早盘涨超9% QX029N近日获批临床 QX030N此前达成国际授权合作","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02509"],"gpt_icon":0},{"id":"2552365654","title":"荃信生物-B07月17日主力净流入183.6万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2552365654","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552365654?lang=zh_cn&edition=full","pubTime":"2025-07-17 16:15","pubTimestamp":1752740119,"startTime":"0","endTime":"0","summary":"07月17日, 荃信生物-B股价涨4.88%，报收15.48元，成交金额806.2万元，换手率0.24%，振幅4.20%，量比2.17。荃信生物-B今日主力资金净流入183.6万元，上一交易日主力净流出0万元。该股近5个交易日上涨1.44%，主力资金累计净流入183.6万元；近20日主力资金累计净流出357.8万元，其中净流出天数为1日。该股主力净额占比0.05%，港股市场排名201/2671。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717170822a6af66de&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717170822a6af66de&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02509"],"gpt_icon":0},{"id":"2551158050","title":"荃信生物-B盘中异动 早盘快速下跌5.61%报14.140港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551158050","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551158050?lang=zh_cn&edition=full","pubTime":"2025-07-15 11:04","pubTimestamp":1752548693,"startTime":"0","endTime":"0","summary":"2025年07月15日早盘11时04分，荃信生物-B股票出现异动，股价急速跳水5.61%。截至发稿，该股报14.140港元/股，成交量6.76万股，换手率0.03%，振幅5.74%。资金方面，该股资金流入9.288万港元，流出90.0944万港元。荃信生物-B股票所在的生物技术行业中，整体涨幅为1.62%。其相关个股中，三叶草生物-B、康宁杰瑞制药-B、欧康维视生物-B涨幅较大，振幅较大的相关个股有北海康成-B、三叶草生物-B、昭衍新药，振幅分别为16.47%、16.42%、9.81%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071511045397a676b4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071511045397a676b4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02509","BK1161"],"gpt_icon":0},{"id":"2550617302","title":"荃信生物-B07月10日主力净流出592.2万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2550617302","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550617302?lang=zh_cn&edition=full","pubTime":"2025-07-10 16:15","pubTimestamp":1752135323,"startTime":"0","endTime":"0","summary":"07月10日, 荃信生物-B股价跌0.26%，报收15.26元，成交金额1019.4万元，换手率0.30%，振幅3.14%，量比7.54。荃信生物-B今日主力资金净流出592.2万元，上一交易日主力净流出0万元。该股近5个交易日下跌0.26%，主力资金累计净流出592.2万元；近20日主力资金累计净流出599.3万元，其中净流出天数为2日。该股主力净额占比0.17%，港股市场排名2634/2673。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710165137a6a13637&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710165137a6a13637&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02509"],"gpt_icon":0},{"id":"2548395766","title":"荃信生物-B(02509)合共认购1.2亿元浦发银行理财产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2548395766","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548395766?lang=zh_cn&edition=full","pubTime":"2025-07-04 20:09","pubTimestamp":1751630960,"startTime":"0","endTime":"0","summary":"智通财经APP讯，荃信生物-B(02509)公布，于2025年7月4日，为有效利用闲置资金，该公司与浦发银行签订了两份认购协议，以认购由浦发银行提供的两项理财产品，认购金额均为6000万元，到期日均为2025年10月9日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1314238.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0015","02509","SGXZ81163826.USD","LU0469268626.HKD","BK0012","BK1161","BK0086","BK0028","600000","LU1808992512.USD","BK0187","SGXZ49509284.SGD","BK0201","LU1934453819.USD","LU1979443071.USD","BK0183","BK0278","BK0188"],"gpt_icon":0},{"id":"2548634853","title":"荃信生物-B盘中异动 早盘大幅下挫5.65%报14.360港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548634853","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548634853?lang=zh_cn&edition=full","pubTime":"2025-07-02 10:44","pubTimestamp":1751424267,"startTime":"0","endTime":"0","summary":"2025年07月02日早盘10时44分，荃信生物-B股票出现异动，股价快速下跌5.65%。截至发稿，该股报14.360港元/股，成交量14万股，换手率0.06%，振幅10.38%。资金方面，该股资金流入138.78万港元，流出58.7152万港元。荃信生物-B股票所在的生物技术行业中，整体跌幅为0.29%。其相关个股中，华昊中天医药-B、加科思-B、嘉和生物-B涨幅较大，振幅较大的相关个股有华昊中天医药-B、科笛-B、来凯医药-B，振幅分别为77.10%、20.26%、12.49%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702104427a4ca1d1a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702104427a4ca1d1a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02509","BK1161"],"gpt_icon":0},{"id":"2543745556","title":"十年跬步，志在千里——荃信生物十周年庆典系列活动隆重举行","url":"https://stock-news.laohu8.com/highlight/detail?id=2543745556","media":"E药经理人","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543745556?lang=zh_cn&edition=full","pubTime":"2025-06-16 18:41","pubTimestamp":1750070488,"startTime":"0","endTime":"0","summary":"2025年6月13日至14日，荃信生物成立十周年庆典系列活动在泰州隆重举行。回顾过去的十年，是荃信生物从无到有、从探索到突破的十年。▋十年来，荃信生物持续强化创新突破，不断完善管治体系。▋十年来，荃信生物不断开拓商业合作，连续验证公司价值。荃信生物十周年主题片《为最大多数病患而创新》于庆典上发布。荃信生物十周年庆典系列活动，不仅是对过往辉煌成就的盛大礼赞，更是面向未来宏伟征程的嘹亮号角。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250616191625a4abfa14&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250616191625a4abfa14&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02509"],"gpt_icon":0},{"id":"2543064180","title":"荃信生物-B盘中异动 股价大跌5.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2543064180","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543064180?lang=zh_cn&edition=full","pubTime":"2025-06-16 11:29","pubTimestamp":1750044548,"startTime":"0","endTime":"0","summary":"2025年06月16日早盘11时29分，荃信生物-B股票出现波动，股价快速下跌5.50%。截至发稿，该股报15.800港元/股，成交量17.16万股，换手率0.08%，振幅7.06%。荃信生物-B股票所在的生物技术行业中，整体跌幅为0.94%。其相关个股中，北海康成-B、歌礼制药-B、帝王国际投资涨幅较大，振幅较大的相关个股有北海康成-B、歌礼制药-B、帝王国际投资，振幅分别为55.38%、18.01%、17.00%。荃信生物-B公司简介：江苏荃信生物医药股份有限公司是一家主要从事生物制药的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025061611290897814c3c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025061611290897814c3c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02509","BK1161"],"gpt_icon":0},{"id":"2543522108","title":"荃信生物-B盘中异动 早盘大幅拉升5.22%报16.540港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2543522108","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543522108?lang=zh_cn&edition=full","pubTime":"2025-06-13 09:32","pubTimestamp":1749778351,"startTime":"0","endTime":"0","summary":"2025年06月13日早盘09时32分，荃信生物-B股票出现波动，股价快速拉升5.22%。截至发稿，该股报16.540港元/股，成交量7.54万股，换手率0.03%，振幅4.33%。资金方面，该股资金流入79.522万港元，流出52.966万港元。荃信生物-B股票所在的生物技术行业中，整体涨幅为0.49%。其相关个股中，荃信生物-B、欧康维视生物-B、和誉-B涨幅较大，振幅较大的相关个股有欧康维视生物-B、维亚生物、北海康成-B，振幅分别为6.04%、5.88%、5.85%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613093231a7065be3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613093231a7065be3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02509","BK1161"],"gpt_icon":0},{"id":"2542027113","title":"荃信生物-B06月11日遭主力抛售104.5万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542027113","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542027113?lang=zh_cn&edition=full","pubTime":"2025-06-11 16:15","pubTimestamp":1749629723,"startTime":"0","endTime":"0","summary":"06月11日, 荃信生物-B股价跌3.52%，报收13.72元，成交金额563.8万元，换手率0.18%，振幅5.20%，量比0.84。荃信生物-B今日主力资金净流出104.5万元，上一交易日主力净流出4.2万元。该股近5个交易日上涨10.29%，主力资金累计净流入47.4万元；近20日主力资金累计净流入187.4万元，其中净流入天数为3日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611173111a4a34859&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611173111a4a34859&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02509","BK1161"],"gpt_icon":0},{"id":"2542350368","title":"荃信生物-B盘中异动 股价大跌5.14%报14.020港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542350368","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542350368?lang=zh_cn&edition=full","pubTime":"2025-06-10 10:02","pubTimestamp":1749520943,"startTime":"0","endTime":"0","summary":"2025年06月10日早盘10时02分，荃信生物-B股票出现异动，股价急速下跌5.14%。截至发稿，该股报14.020港元/股，成交量8.68万股，换手率0.04%，振幅6.77%。资金方面，该股资金流入9.62万港元，流出107.681万港元。荃信生物-B股票所在的生物技术行业中，整体涨幅为0.71%。其相关个股中，博安生物、北海康成-B、帝王国际投资涨幅较大，振幅较大的相关个股有帝王国际投资、北海康成-B、中国抗体-B，振幅分别为18.60%、14.67%、13.57%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506101002239778b01f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506101002239778b01f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02509"],"gpt_icon":0},{"id":"2541088892","title":"荃信生物-B盘中异动 快速上涨5.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2541088892","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541088892?lang=zh_cn&edition=full","pubTime":"2025-06-06 09:35","pubTimestamp":1749173747,"startTime":"0","endTime":"0","summary":"2025年06月06日早盘09时35分，荃信生物-B股票出现异动，股价急速拉升5.42%。截至发稿，该股报14.780港元/股，成交量1.28万股，换手率0.01%，振幅4.14%。荃信生物-B股票所在的生物技术行业中，整体涨幅为0.22%。其相关个股中，北海康成-B、中国抗体-B、荃信生物-B涨幅较大，振幅较大的相关个股有中国抗体-B、歌礼制药-B、北海康成-B，振幅分别为7.63%、7.38%、6.90%。荃信生物-B公司简介：江苏荃信生物医药股份有限公司是一家主要从事生物制药的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506060935479510b706&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506060935479510b706&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02509","BK1161"],"gpt_icon":0},{"id":"2541017362","title":"荃信生物-B涨超11% QX030N此前达成国际授权合作 赛乐信今年销售额预计达3亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2541017362","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541017362?lang=zh_cn&edition=full","pubTime":"2025-06-05 11:38","pubTimestamp":1749094687,"startTime":"0","endTime":"0","summary":"荃信生物-b涨超11%，截至发稿，涨11.09%，报13.82港元，成交额296.02万港元。消息面上，今年4月，荃信生物宣布与Caldera Therapeutics就荃信生物自主研发的临床前阶段长效自免双抗QX030N签订授权许可协议，授予Caldera开发及商业化QX030N的全球独家许可。根据协议，Caldera获授予研究、开发、注册、生产及商业化QX030N的全球独家权益。此外，荃信生物2024年实现收入人民币1.59亿元；净亏损同比收窄32.92%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250605114457a49ac5af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250605114457a49ac5af&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02509","BK1161"],"gpt_icon":0},{"id":"2540203697","title":"荃信生物-B盘中异动 下午盘股价大涨5.02%报12.560港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2540203697","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540203697?lang=zh_cn&edition=full","pubTime":"2025-06-04 13:53","pubTimestamp":1749016406,"startTime":"0","endTime":"0","summary":"2025年06月04日下午盘13时53分，荃信生物-B股票出现波动，股价急速上涨5.02%。截至发稿，该股报12.560港元/股，成交量7.46万股，换手率0.03%，振幅3.85%。资金方面，该股资金流入54.7268万港元，流出31.6564万港元。荃信生物-B股票所在的生物技术行业中，整体涨幅为2.68%。荃信生物-B公司简介：江苏荃信生物医药股份有限公司是一家主要从事生物制药的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506041353269770ffea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506041353269770ffea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02509"],"gpt_icon":0},{"id":"2540744259","title":"荃信生物-B盘中异动 下午盘急速上涨5.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2540744259","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540744259?lang=zh_cn&edition=full","pubTime":"2025-06-03 13:41","pubTimestamp":1748929260,"startTime":"0","endTime":"0","summary":"2025年06月03日下午盘13时41分，荃信生物-B股票出现波动，股价大幅上涨5.73%。截至发稿，该股报12.180港元/股，成交量6.5万股，换手率0.03%，振幅7.99%。荃信生物-B股票所在的生物技术行业中，整体涨幅为1.66%。其相关个股中，中国抗体-B、映恩生物-B、三叶草生物-B涨幅较大，振幅较大的相关个股有中国抗体-B、宜明昂科-B、科笛-B，振幅分别为54.90%、11.94%、11.66%。荃信生物-B公司简介：江苏荃信生物医药股份有限公司是一家主要从事生物制药的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250603134100a6f81686&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250603134100a6f81686&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02509","BK1161"],"gpt_icon":0},{"id":"2535275155","title":"荃信生物-B盘中异动 股价大涨5.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2535275155","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535275155?lang=zh_cn&edition=full","pubTime":"2025-05-13 10:03","pubTimestamp":1747101796,"startTime":"0","endTime":"0","summary":"2025年05月13日早盘10时03分，荃信生物-B股票出现波动，股价快速拉升5.98%。截至发稿，该股报11.700港元/股，成交量3.38万股，换手率0.02%，振幅3.26%。荃信生物-B股票所在的生物技术行业中，整体涨幅为1.48%。其相关个股中，荣昌生物、复宏汉霖、来凯医药-B涨幅较大，振幅较大的相关个股有永泰生物-B、基石药业-B、同源康医药-B，振幅分别为11.21%、8.00%、6.94%。荃信生物-B公司简介：江苏荃信生物医药股份有限公司是一家主要从事生物制药的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250513100316a6dce37f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250513100316a6dce37f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02509"],"gpt_icon":0},{"id":"2531211927","title":"荃信生物-B盘中异动 早盘快速拉升5.18%报11.780港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531211927","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531211927?lang=zh_cn&edition=full","pubTime":"2025-04-29 09:53","pubTimestamp":1745891585,"startTime":"0","endTime":"0","summary":"2025年04月29日早盘09时53分，荃信生物-B股票出现异动，股价急速上涨5.18%。截至发稿，该股报11.780港元/股，成交量1.52万股，换手率0.01%，振幅6.96%。资金方面，该股资金流入3.6224万港元，流出13.272万港元。荃信生物-B股票所在的生物技术行业中，整体涨幅为1.60%。荃信生物-B公司简介：江苏荃信生物医药股份有限公司是一家主要从事生物制药的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429095305a6cc7a3f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429095305a6cc7a3f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02509"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.qyuns.net","stockEarnings":[{"period":"1week","weight":0.1145},{"period":"1month","weight":0.3239},{"period":"3month","weight":0.8252},{"period":"6month","weight":1.099},{"period":"1year","weight":-0.1875},{"period":"ytd","weight":1.7304}],"compareEarnings":[{"period":"1week","weight":-0.0141},{"period":"1month","weight":0.0459},{"period":"3month","weight":0.1382},{"period":"6month","weight":0.2448},{"period":"1year","weight":0.4807},{"period":"ytd","weight":0.2551}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"江苏荃信生物医药股份有限公司是一家主要从事生物制药的中国公司。该公司主要从事自身免疫及过敏性疾病生物疗法的生物科技研发。该公司业务主要涵盖四大疾病领域，包括皮肤、风湿、呼吸道及消化道疾病。该公司正在研发的项目有8个，目标适应症包括银屑病、特应性皮炎、类风湿性关节炎、炎症性肠病、哮喘等。该公司核心产品有QX002N和QX005N。","exchange":"SEHK","name":"荃信生物-B","nameEN":"QYUNS-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.4","shortVersion":"4.34.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"荃信生物-B(02509)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供荃信生物-B(02509)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"荃信生物-B,02509,荃信生物-B股票,荃信生物-B股票老虎,荃信生物-B股票老虎国际,荃信生物-B行情,荃信生物-B股票行情,荃信生物-B股价,荃信生物-B股市,荃信生物-B股票价格,荃信生物-B股票交易,荃信生物-B股票购买,荃信生物-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"荃信生物-B(02509)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供荃信生物-B(02509)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}